SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-279958
Filing Date
2023-11-17
Accepted
2023-11-17 18:26:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6757
2 GRAPHIC g541146snap1.jpg GRAPHIC 1696
  Complete submission text file 0001193125-23-279958.txt   10324
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)